189 related articles for article (PubMed ID: 30858129)
1. Assessment of salivary endothelin-1 in patients with leukoplakia, submucous fibrosis, oral cancer and healthy individuals - a comparative study.
Ankita K; Shwetha V; Vanitha S; Reddy Sujatha S; Nagaraju R; Tupakula Pavan K
J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):326-331. PubMed ID: 30858129
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
3. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
5. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
6. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
8. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
10. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
Rai B; Kaur J; Jacobs R; Singh J
J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
[TBL] [Abstract][Full Text] [Related]
11. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.
Yasothkumar D; Ramani P; Jayaraman S; Ramalingam K; Tilakaratne WM
Head Neck Pathol; 2024 Mar; 18(1):28. PubMed ID: 38536520
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
Ganavi BS; Patil S; Rao RS
J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
[TBL] [Abstract][Full Text] [Related]
13. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
Punyani SR; Sathawane RS
Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of salivary endothelin-1 as a biomarker for oral cancer and precancer.
Irfan S; Zaidi N; Tiwari K; Lal N; Srivastava AN; Singh S
J Cancer Res Ther; 2023 Dec; ():. PubMed ID: 38102911
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
16. Investigating the level of salivary endothelin-1 in premalignant and malignant lesions.
Nosratzehi T; Risbaf Fakour S; Alijani E; Salehi M
Spec Care Dentist; 2017 May; 37(3):134-139. PubMed ID: 28199027
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
Kaur J; Jacobs R
J Korean Assoc Oral Maxillofac Surg; 2015 Aug; 41(4):171-5. PubMed ID: 26339574
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
[TBL] [Abstract][Full Text] [Related]
19. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
20. Salivary interleukin-6 in the detection of oral cancer and precancer.
Panneer Selvam N; Sadaksharam J
Asia Pac J Clin Oncol; 2015 Sep; 11(3):236-41. PubMed ID: 25560781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]